Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Sacituzumab Govitecan Produced Overall Response Rate of 31 Percent in Patients Post Endocrine Treatment ...
-- Filgotinib 100 mg and 200 mg Doses Achieved Significantly Higher ACR20/50/70 Responses than ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
